Insider · CIK 0001726096
Richard Daniell
officer
Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). First filing Mar 5, 2025, latest Mar 7, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $4.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TEVA: TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVAOct 9, 2026 · close 41.10
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | TEVA PHARMACEUTICAL INDUSTRIES LTD | $1.1M 70,961 shares | -59% | - | |
| 40Moderate | TEVA PHARMACEUTICAL INDUSTRIES LTD | $2.2M 140,372 shares | -419% | - | |
| 40Moderate | TEVA PHARMACEUTICAL INDUSTRIES LTD | $999k 62,250 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +22,576 | - | - | 119,345 | Mar 7, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -22,576 | $15.91 | $359k | 96,769 | Mar 7, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -48,385 | $15.90 | $769k | 48,384 | Mar 7, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -22,576 | $0.00 | $0 | 0 | Mar 7, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | AGrant or award Restricted Share Unitsderivative10b5-1 | +69,182 | $0.00 | $0 | 69,182 | Mar 7, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +33,512 | - | - | 33,512 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -21,870 | $15.73 | $344k | 11,641 | Mar 6, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -11,641 | $15.91 | $185k | 0 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +20,461 | - | - | 20,461 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -13,353 | $15.73 | $210k | 7,108 | Mar 6, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -7,108 | $15.91 | $113k | 0 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +183,169 | - | - | 183,169 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -56,385 | $15.73 | $887k | 126,784 | Mar 6, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -30,015 | $15.91 | $478k | 96,769 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -33,512 | $0.00 | $0 | 33,512 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -20,461 | $0.00 | $0 | 61,384 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -183,169 | $0.00 | $0 | 0 | Mar 6, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +62,250 | - | - | 62,250 | Mar 5, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -49,314 | $16.19 | $798k | 12,936 | Mar 5, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -12,936 | $15.56 | $201k | 0 | Mar 5, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -62,250 | $0.00 | $0 | 124,503 | Mar 5, 2025 |
| Jan 28, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | AGrant or award Restricted Share Unitsderivative | +183,169 | $0.00 | $0 | 183,169 | Jan 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.